Gram-scale synthesis of the p38a MAPK-inhibitor VX-745 for preclinical studies into Werner syndrome (2010)
Attributed to:
Dissecting the cause of premature replicative senescence of Werner syndrome cells using selective chemical inhibitors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.4155/fmc.10.217
PubMed Identifier: 21426137
Publication URI: http://europepmc.org/abstract/MED/21426137
Type: Journal Article/Review
Parent Publication: Future Medicinal Chemistry
Issue: 9
ISSN: 1756-8919